首页>
外国专利>
USE OF A DOMAIN ANTIBODY (DAB) THAT BINDS A TARGET IN PULMONARY TISSUE FOR THE MANUFACTURE OF A LONG ACTION OR LONG THERAPEUTIC WINDOW FORMULATION FOR LOCAL DELIVERY TO PULMONARY TISSUE
USE OF A DOMAIN ANTIBODY (DAB) THAT BINDS A TARGET IN PULMONARY TISSUE FOR THE MANUFACTURE OF A LONG ACTION OR LONG THERAPEUTIC WINDOW FORMULATION FOR LOCAL DELIVERY TO PULMONARY TISSUE
展开▼
机译:使用绑定在肺组织中的靶标的领域抗体(DAB)制造长效或长治疗窗制剂以局部递送至肺组织
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is the use of an agent (e.g., antibody fragment, antagonist, ligand, dAb monomer) that binds a target in pulmonary tissue for the manufacture of a long action or long therapeutic window formulation for local delivery to pulmonary tissue, and methods for administering an agent that binds a target in pulmonary tissue to a subject to produce a long therapeutic window in pulmonary tissue. The formulation is for, and the method comprises, administering locally to pulmonary tissue. Also disclosed is the use of antagonists of TNFR1 for the manufacture of a formulation or medicament for treating, preventing or suppressing lung inflammation or a respiratory disease, and methods of treating such diseases. Also disclosed arc the use of agents a for the manufacture of a delivery device (e.g., inhaler, intranasal delivery device) for the treatment or prevention of lung inflammation or a respiratory disease, and a delivery device for the treatment or prevention of lung inflammation or a respiratory disease that contains an agent as described herein.
展开▼